Guangbo Ge

1.8k total citations · 1 hit paper
92 papers, 1.4k citations indexed

About

Guangbo Ge is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Guangbo Ge has authored 92 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 25 papers in Pharmacology and 17 papers in Oncology. Recurrent topics in Guangbo Ge's work include Pharmacogenetics and Drug Metabolism (12 papers), Computational Drug Discovery Methods (11 papers) and Pharmacological Effects of Natural Compounds (9 papers). Guangbo Ge is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Computational Drug Discovery Methods (11 papers) and Pharmacological Effects of Natural Compounds (9 papers). Guangbo Ge collaborates with scholars based in China, United States and United Kingdom. Guangbo Ge's co-authors include Ling Yang, Yanyan Zhang, Da‐Cheng Hao, Peigen Xiao, Yong Liu, Li‐Wei Zou, Xing‐Kai Qian, Bei Zhao, Zhong‐Ze Fang and Liangliang Zhu and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Biomaterials.

In The Last Decade

Guangbo Ge

89 papers receiving 1.4k citations

Hit Papers

Astragalus polysaccharide... 2023 2026 2024 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guangbo Ge China 21 612 324 216 215 213 92 1.4k
Ziru Dai China 21 823 1.3× 347 1.1× 121 0.6× 236 1.1× 167 0.8× 45 1.7k
Gurdarshan Singh India 22 549 0.9× 232 0.7× 181 0.8× 215 1.0× 146 0.7× 73 1.4k
Ean‐Jeong Seo Germany 22 686 1.1× 197 0.6× 154 0.7× 185 0.9× 314 1.5× 57 1.5k
Zhixing Cao China 25 902 1.5× 202 0.6× 151 0.7× 233 1.1× 216 1.0× 74 2.0k
Raju S. Kanumuri India 23 492 0.8× 474 1.5× 108 0.5× 245 1.1× 424 2.0× 99 1.7k
Nand Kishor Roy India 22 1.2k 2.0× 279 0.9× 254 1.2× 493 2.3× 180 0.8× 30 2.4k
José Manuel Calderón‐Montaño Spain 20 1.1k 1.8× 196 0.6× 284 1.3× 219 1.0× 264 1.2× 50 2.2k
Jinping Hu China 19 484 0.8× 258 0.8× 205 0.9× 101 0.5× 155 0.7× 76 1.0k
Bum Sang Shim South Korea 26 1.1k 1.7× 275 0.8× 383 1.8× 193 0.9× 138 0.6× 62 1.9k

Countries citing papers authored by Guangbo Ge

Since Specialization
Citations

This map shows the geographic impact of Guangbo Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangbo Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangbo Ge more than expected).

Fields of papers citing papers by Guangbo Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangbo Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangbo Ge. The network helps show where Guangbo Ge may publish in the future.

Co-authorship network of co-authors of Guangbo Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Guangbo Ge. A scholar is included among the top collaborators of Guangbo Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangbo Ge. Guangbo Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Wenchao, Guanghao Zhu, Xue Zhang, et al.. (2025). Rationally engineered a universal far-red fluorogenic substrate of bile salt hydrolase for functional imaging and inhibitor screening. Chinese Chemical Letters. 37(4). 111320–111320.
2.
Yao, Cheng, Baosheng Wang, Yuyang Zhang, et al.. (2025). Near‐Infrared Biosensing of Drug‐Induced Cell‐Heterogeneous Injuries with an Ultrahigh Turn‐On Ratio. Angewandte Chemie. 137(33).
3.
Yao, Cheng, Baosheng Wang, Yuyang Zhang, et al.. (2025). Near‐Infrared Biosensing of Drug‐Induced Cell‐Heterogeneous Injuries with an Ultrahigh Turn‐On Ratio. Angewandte Chemie International Edition. 64(33). e202503579–e202503579. 1 indexed citations
4.
Zhu, Rong, Pu Wang, Shenglan Qi, et al.. (2025). Discovery and optimization of a novel non-nitrocatechol COMT inhibitor for modulating levodopa metabolism. Journal of Pharmaceutical Analysis. 101520–101520. 1 indexed citations
5.
Li, Hao, Xiaodong Li, Chunyang Yu, et al.. (2024). Activity-based NIR specific fluorescent probe reveals the abnormal elevation of prolyl endopeptidase in hippocampus during Alzheimer's disease progression. Sensors and Actuators B Chemical. 417. 136071–136071. 6 indexed citations
6.
Hu, Qing, Yiwen Zhang, Pengcheng Chen, et al.. (2024). Discovery and characterization of naturally occurring covalent inhibitors of SARS-CoV-2 Mpro from the antiviral herb Ephedra. Chinese Journal of Natural Medicines. 22(9). 797–807. 1 indexed citations
7.
Lü, Jun, Shanshan Yu, Xinyan Jin, et al.. (2024). Danggui Liuhuang Decoction ameliorates endothelial dysfunction by inhibiting the JAK2/STAT3 mediated inflammation. Journal of Ethnopharmacology. 340. 119170–119170. 3 indexed citations
9.
Li, Qian, et al.. (2024). Pectolinarigenin ameliorates osteoporosis via enhancing Wnt signaling cascade in PPARβ-dependent manner. Phytomedicine. 129. 155587–155587. 3 indexed citations
10.
Wang, Boya, et al.. (2024). Pharmacological modulation of mitochondrial function as novel strategies for treating intestinal inflammatory diseases and colorectal cancer. Journal of Pharmaceutical Analysis. 15(4). 101074–101074. 3 indexed citations
11.
Zhang, Jiaxin, Leaf Huang, Guangbo Ge, & Kaili Hu. (2023). Emerging Epigenetic‐Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment. Advanced Science. 10(7). e2206169–e2206169. 32 indexed citations
12.
Zhang, Na, Guanghao Zhu, Yufan Fan, et al.. (2023). Functional Imaging and Inhibitor Screening of Human Pancreatic Lipase by a Resorufin-Based Fluorescent Probe. Biosensors. 13(2). 283–283. 4 indexed citations
13.
Zhao, Bei, Hongping Yin, Jie Gao, et al.. (2023). Astragalus polysaccharide ameliorates vascular endothelial dysfunction by stimulating macrophage M2 polarization via potentiating Nrf2/HO-1 signaling pathway. Phytomedicine. 112. 154667–154667. 90 indexed citations breakdown →
14.
Zhang, Na, Xudong Hou, Wei Liu, et al.. (2023). A rationally engineered specific near-infrared fluorogenic substrate of human pancreatic lipase for functional imaging and inhibitor screening. The Analyst. 148(10). 2225–2236. 1 indexed citations
15.
Khan, Abbas, Heng Wang, Guanghao Zhu, et al.. (2023). Discovery of Isojacareubin as a covalent inhibitor of SARS‐CoV‐2 main protease using structural and experimental approaches. Journal of Medical Virology. 95(2). e28542–e28542. 6 indexed citations
16.
Zhang, Jingfang, Yun‐Qing Song, Gui‐Yang Xia, et al.. (2021). Paeonone A, a novel nonanortriterpenoid from the roots of Paeonia lactiflora. Bioorganic Chemistry. 110. 104783–104783. 5 indexed citations
18.
Tian, Xiangge, Chao Wang, Peipei Dong, et al.. (2018). Arenobufagin is a novel isoform-specific probe for sensing human sulfotransferase 2A1. Acta Pharmaceutica Sinica B. 8(5). 784–794. 10 indexed citations
19.
Hao, Da‐Cheng, Guangbo Ge, Pei‐Gen Xiao, Ping Wang, & Ling Yang. (2015). Drug Metabolism and Pharmacokinetic Diversity of Ranunculaceae Medicinal Compounds. Current Drug Metabolism. 16(4). 294–321. 17 indexed citations
20.
Zhang, Yan, Chaoran Wang, Lien Wang, et al.. (2014). A Novel Analgesic Isolated from a Traditional Chinese Medicine. Current Biology. 24(2). 117–123. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026